Thermo Fisher Scientific Inc. (NYSE:TMO) is a top low volatility healthcare stock with promising growth prospects. Recently, Barclays analyst Luke Sergott raised the price target on TMO, highlighting its strong Q2 performance. With a focus on analytical instruments, reagents, equipment, software, and other services, TMO is well-positioned for success in analysis, research, diagnostics, and discovery.
While TMO shows promise as an investment, exploring AI stocks with greater upside potential and lower downside risk may also be advantageous. Discover an undervalued AI stock poised to benefit from Trump-era tariffs and the onshoring trend in our free report. For more insights on potential investment opportunities, consider exploring our recommendations for stocks expected to double in three years and hidden AI stocks worth buying now.
Read more from uk.finance.yahoo.com